{"id": "179637", "url": "https://fevir.net/resources/Citation/179637", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation"], "versionId": "21", "lastUpdated": "2025-10-13T12:34:35.118Z"}, "title": "18508207 A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.", "author": [{"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "contained": [{"id": "contributor0", "name": [{"given": ["Elmer"], "family": "Yu"}], "resourceType": "Practitioner"}, {"id": "contributor1", "name": [{"given": ["Karen"], "family": "Miotto"}], "resourceType": "Practitioner"}, {"id": "contributor2", "name": [{"given": ["Evaristo"], "family": "Akerele"}], "resourceType": "Practitioner"}, {"id": "contributor3", "name": [{"given": ["Ann"], "family": "Montgomery"}], "resourceType": "Practitioner"}, {"id": "contributor4", "name": [{"given": ["Ahmed"], "family": "Elkashef"}], "resourceType": "Practitioner"}, {"id": "contributor5", "name": [{"given": ["Robert"], "family": "Walsh"}], "resourceType": "Practitioner"}, {"id": "contributor6", "name": [{"given": ["Ivan"], "family": "Montoya"}], "resourceType": "Practitioner"}, {"id": "contributor7", "name": [{"given": ["Marian W"], "family": "Fischman"}], "resourceType": "Practitioner"}, {"id": "contributor8", "name": [{"given": ["Joseph"], "family": "Collins"}], "resourceType": "Practitioner"}, {"id": "contributor9", "name": [{"given": ["Frances"], "family": "McSherry"}], "resourceType": "Practitioner"}, {"id": "contributor10", "name": [{"given": ["Kathy"], "family": "Boardman"}], "resourceType": "Practitioner"}, {"id": "contributor11", "name": [{"given": ["David K"], "family": "Davies"}], "resourceType": "Practitioner"}, {"id": "contributor12", "name": [{"given": ["Charles P"], "family": "O'Brien"}], "resourceType": "Practitioner"}, {"id": "contributor13", "name": [{"given": ["Walter"], "family": "Ling"}], "resourceType": "Practitioner"}, {"id": "contributor14", "name": [{"given": ["Herbert"], "family": "Kleber"}], "resourceType": "Practitioner"}, {"id": "contributor15", "name": [{"given": ["Barbara H"], "family": "Herman"}], "resourceType": "Practitioner"}, {"id": "meshHeading0", "content": [{"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000009", "system": "https://www.nlm.nih.gov/mesh", "display": "adverse effects"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D000316", "system": "https://www.nlm.nih.gov/mesh", "display": "Adrenergic alpha-Agonists", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D000328", "system": "https://www.nlm.nih.gov/mesh", "display": "Adult", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is Major topic"}]}], "classifier": [{"coding": [{"code": "D000701", "system": "https://www.nlm.nih.gov/mesh", "display": "Analgesics, Opioid", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000009", "system": "https://www.nlm.nih.gov/mesh", "display": "adverse effects"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000031", "system": "https://www.nlm.nih.gov/mesh", "display": "analogs & derivatives"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D003000", "system": "https://www.nlm.nih.gov/mesh", "display": "Clonidine", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D003625", "system": "https://www.nlm.nih.gov/mesh", "display": "Data Collection", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D004311", "system": "https://www.nlm.nih.gov/mesh", "display": "Double-Blind Method", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D005260", "system": "https://www.nlm.nih.gov/mesh", "display": "Female", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D006801", "system": "https://www.nlm.nih.gov/mesh", "display": "Humans", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008297", "system": "https://www.nlm.nih.gov/mesh", "display": "Male", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008875", "system": "https://www.nlm.nih.gov/mesh", "display": "Middle Aged", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D011569", "system": "https://www.nlm.nih.gov/mesh", "display": "Psychiatric Status Rating Scales", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D015813", "system": "https://www.nlm.nih.gov/mesh", "display": "Substance Abuse Detection", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000188", "system": "https://www.nlm.nih.gov/mesh", "display": "drug therapy"}]}]}], "classifier": [{"coding": [{"code": "D013375", "system": "https://www.nlm.nih.gov/mesh", "display": "Substance Withdrawal Syndrome", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D016019", "system": "https://www.nlm.nih.gov/mesh", "display": "Survival Analysis", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D016896", "system": "https://www.nlm.nih.gov/mesh", "display": "Treatment Outcome", "userSelected": false}]}], "freeToShare": true}], "resourceType": "ArtifactAssessment", "artifactReference": {"type": "Citation", "reference": "#"}}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "179637", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"value": "18508207", "system": "https://pubmed.ncbi.nlm.nih.gov"}], "statusDate": [{"period": {"end": "2007-11-22"}, "activity": {"coding": [{"code": "pubmed-pubstatus-received", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Received"}]}}, {"period": {"end": "2008-04-08"}, "activity": {"coding": [{"code": "pubmed-pubstatus-revised", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Revised"}]}}, {"period": {"end": "2008-04-09"}, "activity": {"coding": [{"code": "pubmed-pubstatus-accepted", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Accepted"}]}}, {"period": {"end": "2008-05-30T09:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-pubmed", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Pubmed"}]}}, {"period": {"end": "2008-12-17T09:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Medline"}]}}, {"period": {"end": "2008-05-30T09:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-entrez", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Entrez"}]}}, {"period": {"end": "2009-09-01"}, "activity": {"coding": [{"code": "pubmed-pubstatus-pmc-release", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of PMC release"}]}}], "useContext": [{"code": {"code": "fevir-platform-use", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"code": "medline-base", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Medline Base", "userSelected": false}]}}], "approvalDate": "2008-12-16", "currentState": [{"coding": [{"code": "medline-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "Medline Citation Status of Medline"}]}, {"coding": [{"code": "pubmed-publication-status-ppublish", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed PublicationStatus of ppublish"}]}], "resourceType": "Citation", "citedArtifact": {"title": [{"text": "A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.", "type": [{"coding": [{"code": "primary", "system": "http://terminology.hl7.org/CodeSystem/title-type", "display": "Primary title"}]}], "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}}], "abstract": [{"text": "**CONTEXT:** Lofexidine is an alpha-2-adrenergic receptor agonist that is approved in the United Kingdom for the treatment of opioid withdrawal symptoms. Lofexidine has been reported to have more significant effects on decreasing opioid withdrawal symptoms with less hypotension than clonidine.\n**OBJECTIVE:** To demonstrate that lofexidine is well tolerated and effective in the alleviation of observationally defined opioid withdrawal symptoms in opioid dependent individuals undergoing medically supervised opioid detoxification as compared to placebo.\n**DESIGN:** An inpatient, Phase 3, placebo-controlled, double-blind, randomized multi-site trial with three phases: (1) opioid agonist stabilization phase (days 1-3), (2) detoxification/medication or placebo phase (days 4-8), and (3) post detoxification/medication phase (days 9-11).\n**SUBJECTS:** Sixty-eight opioid dependent subjects were enrolled at three sites with 35 randomized to lofexidine and 33 to placebo.\n**MAIN OUTCOME MEASURE:** Modified Himmelsbach Opiate Withdrawal Scale (MHOWS) on study day 5 (second opioid detoxification treatment day).\n**RESULTS:** Due to significant findings, the study was terminated early. On the study day 5 MHOWS, subjects treated with lofexidine had significantly lower scores (equating to fewer/less severe withdrawal symptoms) than placebo subjects (least squares means 19.5+/-2.1 versus 30.9+/-2.7; p=0.0019). Lofexidine subjects had significantly better retention in treatment than placebo subjects (38.2% versus 15.2%; Log rank test p=0.01).\n**CONCLUSIONS:** Lofexidine is well tolerated and more efficacious than placebo for reducing opioid withdrawal symptoms in inpatients undergoing medically supervised opioid detoxification.", "type": {"coding": [{"code": "primary-human-use", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type", "display": "Primary human use"}]}}], "relatesTo": [{"type": "cites", "citation": "Aghajanian GK. Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors. J Clin Psychiatry. 1982;43(6 Pt 2):20\u201324.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/6282816/", "identifier": {"value": "6282816", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Aghajanian GK. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 1978;276(5684):186\u2013188.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/216919/", "identifier": {"value": "216919", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Aigner A, Schmidt U. Lofexidine, a new, antihypertensive imidazoline derivative. Clinical profile of action with single-drug treatment and in combination with hydrochlorothiazide. Arzneimittelforschung. 1982;32(8a):976\u2013983.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/6890373/", "identifier": {"value": "6890373", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Akhurst JS. The use of lofexidine by drug dependency units in the United Kingdom. Eur Addict Res. 1999;5(1):43\u201349.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/10085500/", "identifier": {"value": "10085500", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Arnsten AF, Cai JX, Goldman-Rakic PS. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J. Neurosci. 1998;8(11):4287\u20134298.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/2903226/", "identifier": {"value": "2903226", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Aston-Jones G, Hirata H, Akaoka H. Local opiate withdrawal in locus coeruleus in vivo. Brain Res. 1997;765(2):331\u2013336.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/9313908/", "identifier": {"value": "9313908", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Bearn J, Gossop M, Strang J. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal. Drug Alcohol Depend. 1996;43(1\u20132):87\u201391.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/8957147/", "identifier": {"value": "8957147", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Bearn J, Gossop M, Strang J. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification. Drug Alcohol Depend. 1998;50:227\u2013232.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/9649976/", "identifier": {"value": "9649976", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Buccafusco JJ, Marshall DC. Dorsal root lesions block the expression of morphine withdrawal elicited from the rat spinal cord. Neurosci Lett. 1985;59(3):319\u2013324.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/4058799/", "identifier": {"value": "4058799", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Carnwath T, Hardman J. Randomised double-blind comparison of lofexidine and clonidine in the out-patient treatment of opiate withdrawal. Drug Alcohol Depend. 1998;50(3):251\u2013254.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/9649979/", "identifier": {"value": "9649979", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Freedman JE, Aghajanian GK. Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: co-localization and interactions during withdrawal. J Neurosci. 1985;5(11):3016\u20133024.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/2997411/", "identifier": {"value": "2997411", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gold MS, Pottash AC, Sweeney DR, Extein I, Annitto WJ. Opiate detoxification with lofexidine. Drug Alcohol Depend. 1981;8(4):307\u2013315.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/7338185/", "identifier": {"value": "7338185", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opin Pharmacother. 2004;5(4):713\u2013725.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/15102558/", "identifier": {"value": "15102558", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gossop M. Clonidine and the treatment of the opiate withdrawal syndrome. Drug Alcohol Depend. 1988;21(3):253\u2013259.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/3048954/", "identifier": {"value": "3048954", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gossop M. The development of a short opiate withdrawal scale. Addict Behav. 1990;15(5):487\u2013490.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/2248123/", "identifier": {"value": "2248123", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gowing LR, Farrell M, Ali RL, White JM. Alpha 2-adrenergic agonists in opioid withdrawal. Addiction. 2002;97(1):49\u201358.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/11895270/", "identifier": {"value": "11895270", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Gowing L, Farrell M, Ali R, White J. Alpha2 adrenergic agonists for the management of opioid withdrawal. The Cochrane Database of Systematic Reviews CD002024. 2004", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/15495025/", "identifier": {"value": "15495025", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987;13(3):293\u2013308.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/3687892/", "identifier": {"value": "3687892", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Herman BH, Vocci F, Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: medication development issues for opiate addiction. Neuropsychopharmacology. 1995;13:269\u2013294.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/8747752/", "identifier": {"value": "8747752", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Herman BH, O'Brien CP. Clinical medications development for opiate addiction: Focus on nonopioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention. Seminars in Neuroscience. 1997;9:158\u2013172."}, {"type": "cites", "citation": "Howells C, Allen S, Gupta J, Stillwell G, Marsden J, Farrell M. Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone. Drug Alcohol Depend. 2002;67(2):169\u2013176.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/12095666/", "identifier": {"value": "12095666", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503\u2013508.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/11343531/", "identifier": {"value": "11343531", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986;43(3):289\u2013294.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/3954551/", "identifier": {"value": "3954551", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Jarrott B, Louis WJ, Summers RJ. Characterization of central alpha-adrenoceptors using 3H-clonidine and its derivatives. Chest. 1983;83 Suppl 2:S339\u2013S340.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/6129948/", "identifier": {"value": "6129948", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Jasinski DR. Assessment of the abuse potentiality of morphine-like drugs (methods used in man) In: Martin WR, editor. Handbook of Experimental Pharmacology. Vol 45. Berlin: Springer-Verlag; 1977. pp. 197\u2013258."}, {"type": "cites", "citation": "Kahn A, Mumford JP, Rogers GA, Beckford H. Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. Drug Alcohol Depend. 1997;44(1):57\u201361.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/9031821/", "identifier": {"value": "9031821", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York: John Wiley & Sons, Inc.; 1980."}, {"type": "cites", "citation": "Kleber HD, Riordan CE, Rounsaville B, Kosten T, Charney D, Gaspari J, Hogan I, O'Connor C. Clonidine in outpatient detoxification from methadone maintenance. Arch Gen Psychiatry. 1985;42(4):391\u2013394.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/3977557/", "identifier": {"value": "3977557", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Kolb MR, Himmelsbach CK. Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes. Amer. J. Psychiatry. 1938;94:759\u2013797."}, {"type": "cites", "citation": "Lin SK, Strang J, Su LW, Tsai CJ, Hu WH. Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend. 1997;48(2):127\u2013133.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/9363412/", "identifier": {"value": "9363412", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Marjamaki A, Luomala K, Ala-Uotila S, Scheinen M. Use of recombinant human alpha 2-adrenoceptors to characterize subtype selectively of antagonist binding. Eur J Pharmacol. 1993;246(3):219\u2013226.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/7901041/", "identifier": {"value": "7901041", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "National Survey on Drug Use and Health. 2006.  [accessed on April 10, 2008].  Availabel at:  http://www.oas.samhsa.gov/nsduh/2k6nsduh/2k6Results.cfm.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/24288193/", "identifier": {"value": "24288193", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "O\u2019Brien PC, Fleming TR. A multiple testing procedure for clinical trails. Biometrics. 1979;35(3):549\u2013556.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/497341/", "identifier": {"value": "497341", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Office of National Drug Control Policy. Heroin Fact Sheet. 2003.  [Accessed February 6, 2006].  Available at:  http://www.whitehousedrugpolicy.gov/publications/factsht/heroin/index.html."}, {"type": "cites", "citation": "Preston KL, Bigelow GE. Pharmacological advances in addiction treatment. Int J Addict. 1985;20(6\u20137):845\u2013867.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/2867050/", "identifier": {"value": "2867050", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Raistrick D, West D, Finnegan O, Thistlethwaite G, Brearley R, Banbery J. A comparison of buprenorphine annd lofexidine for community opiate detoxification: results from a randomized controlled trail. Addict. 2005;100(12):1860\u20131867.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/16367987/", "identifier": {"value": "16367987", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Shearman GT, Lal H, Ursillo RC. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat. Pharmacol Biochem Behav. 1980;12(4):573\u2013575.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/7190295/", "identifier": {"value": "7190295", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Snedecor GW, Cochran WG. Statistical Methods. Ames, IA: Iowa State University Press; 1967."}, {"type": "cites", "citation": "Substance Abuse and Mental Health Data Archive. National Household Survey on Drug Abuse (NHSDA) series. 2003.  [Accessed February 6, 2006].  Available at  http://www.icpsr.umich.edu/SAMHDA/ and  http://webapp.icpsr.umich.edu/cocoon/SAMHDA-SERIES/00064.xml."}, {"type": "cites", "citation": "Uhlen S, Wikberg JE. Delineation of three pharmacological subtypes of alpha 2-adrenoceptor in the rat kidney. Br J Pharmacol. 1991;104(3):657\u20136419.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/1665747/", "identifier": {"value": "1665747", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Vocci FJ. Opiates and addiction. In: Sibley DR, Hanin I, Kuhar M, Skolnick P, editors. Handbook of Contemporary Neuropharmacology Volume 2. John Wiley and Sons publisher; 2007. pp. 691\u2013705."}, {"type": "cites", "citation": "Washton AM, Resnick RB, Perzel JF, Garwood J. Opiate detoxification using lofexidine. NIDA Res Monogr. 1982;41:261\u2013263.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/6811916/", "identifier": {"value": "6811916", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "White R, Alcorn R, Feinmann C. Two methods of community detoxification from opiates: an open-label comparison of lofexidine and buprenorphine. Drug Alcohol Depend. 2001;65(1):77\u201383.", "classifier": [{"coding": [{"code": "D016428", "system": "http://hl7.org/fhir/citation-artifact-classifier", "display": "Journal Article"}]}], "targetReference": {"type": "Citation", "reference": "https://pubmed.ncbi.nlm.nih.gov/11714592/", "identifier": {"value": "11714592", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}, {"type": "cites", "citation": "Yu E, Herman BH, Miotto K, Montgomery A, Fudala PJ, Chiang CN, Fisher C, Kampman K, Dhopesh V, Cornish J, Walsh B, Davies K, Vocci F, Bridge P, Ling W, O\u2019Brien CP. NIDA Research Monograph. Rockville: DHHS/NIH/NIDA; 1999. In-patient safety evaluation of lofexidine (alpha-2 adrenergic agonist) for opiate withdrawal; p. 227."}, {"type": "cites", "citation": "Yu E, Herman BH, Miotto K, Montgomery A, Fudala PJ, Chiang CN, Fisher C, Kampman K, Dhopesh V, Cornish J, Walsh B, Davies K, Vocci F, Bridge P, Ling W, O\u2019Brien CP. In-patient safety evaluation of lofexidine (alpha-2 adrenergic agonist) for opiate detoxification. Drug Alcohol Depend. 2001;63:S175."}], "identifier": [{"value": "18508207", "system": "https://pubmed.ncbi.nlm.nih.gov"}, {"type": {"text": "mid", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "NIHMS61453"}, {"value": "PMC2613766", "system": "https://www.ncbi.nlm.nih.gov/pmc/"}, {"value": "10.1016/j.drugalcdep.2008.04.002", "system": "https://doi.org"}, {"type": {"text": "pii", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "S0376-8716(08)00140-3"}], "webLocation": [{"url": "https://pubmed.ncbi.nlm.nih.gov/18508207/", "classifier": [{"coding": [{"code": "abstract", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "Abstract"}]}]}, {"url": "https://doi.org/10.1016/j.drugalcdep.2008.04.002", "classifier": [{"coding": [{"code": "doi-based", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"code": "publishing-model", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"code": "Print-Electronic", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"code": "chemical", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D000316", "system": "https://www.nlm.nih.gov/mesh", "display": "Adrenergic alpha-Agonists", "userSelected": false}]}, {"coding": [{"code": "D000701", "system": "https://www.nlm.nih.gov/mesh", "display": "Analgesics, Opioid", "userSelected": false}]}, {"coding": [{"code": "MN3L5RMN02", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "D003000", "system": "https://www.nlm.nih.gov/mesh", "display": "Clonidine", "userSelected": false}]}, {"coding": [{"code": "UI82K0T627", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "C025655", "system": "https://www.nlm.nih.gov/mesh", "display": "lofexidine", "userSelected": false}]}]}, {"type": {"coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "artifactAssessment": [{"type": "ArtifactAssessment", "reference": "#meshHeading0"}]}, {"type": {"coding": [{"code": "publication-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publication type"}]}, "classifier": [{"coding": [{"code": "D017428", "system": "https://www.nlm.nih.gov/mesh", "display": "Clinical Trial, Phase III", "userSelected": false}]}, {"coding": [{"code": "D016428", "system": "https://www.nlm.nih.gov/mesh", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"code": "D016448", "system": "https://www.nlm.nih.gov/mesh", "display": "Multicenter Study", "userSelected": false}]}, {"coding": [{"code": "D016449", "system": "https://www.nlm.nih.gov/mesh", "display": "Randomized Controlled Trial", "userSelected": false}]}, {"coding": [{"code": "D052061", "system": "https://www.nlm.nih.gov/mesh", "display": "Research Support, N.I.H., Extramural", "userSelected": false}]}, {"coding": [{"code": "D013486", "system": "https://www.nlm.nih.gov/mesh", "display": "Research Support, U.S. Gov't, Non-P.H.S.", "userSelected": false}]}]}, {"type": {"coding": [{"code": "knowledge-artifact-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D016428", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}, {"type": {"coding": [{"code": "citation-subset", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Citation subset", "userSelected": false}]}, "classifier": [{"coding": [{"code": "IM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "display": "IM", "userSelected": false}]}]}], "contributorship": {"entry": [{"affiliation": [{"display": "University of Pennsylvania & Philadelphia Veterans Affairs Medical Center, Philadelphia VAMC 116, University & Woodland Avenues, Philadelphia, PA 19104, USA. yu_e@mail.trc.upenn.edu <yu_e@mail.trc.upenn.edu>"}], "contributor": {"type": "Practitioner", "display": "Yu E", "reference": "#contributor0"}, "forenameInitials": "E"}, {"contributor": {"type": "Practitioner", "display": "Miotto K", "reference": "#contributor1"}, "forenameInitials": "K"}, {"contributor": {"type": "Practitioner", "display": "Akerele E", "reference": "#contributor2"}, "forenameInitials": "E"}, {"contributor": {"type": "Practitioner", "display": "Montgomery A", "reference": "#contributor3"}, "forenameInitials": "A"}, {"contributor": {"type": "Practitioner", "display": "Elkashef A", "reference": "#contributor4"}, "forenameInitials": "A"}, {"contributor": {"type": "Practitioner", "display": "Walsh R", "reference": "#contributor5"}, "forenameInitials": "R"}, {"contributor": {"type": "Practitioner", "display": "Montoya I", "reference": "#contributor6"}, "forenameInitials": "I"}, {"contributor": {"type": "Practitioner", "display": "Fischman MW", "reference": "#contributor7"}, "forenameInitials": "MW"}, {"contributor": {"type": "Practitioner", "display": "Collins J", "reference": "#contributor8"}, "forenameInitials": "J"}, {"contributor": {"type": "Practitioner", "display": "McSherry F", "reference": "#contributor9"}, "forenameInitials": "F"}, {"contributor": {"type": "Practitioner", "display": "Boardman K", "reference": "#contributor10"}, "forenameInitials": "K"}, {"contributor": {"type": "Practitioner", "display": "Davies DK", "reference": "#contributor11"}, "forenameInitials": "DK"}, {"contributor": {"type": "Practitioner", "display": "O'Brien CP", "reference": "#contributor12"}, "forenameInitials": "CP"}, {"contributor": {"type": "Practitioner", "display": "Ling W", "reference": "#contributor13"}, "forenameInitials": "W"}, {"contributor": {"type": "Practitioner", "display": "Kleber H", "reference": "#contributor14"}, "forenameInitials": "H"}, {"contributor": {"type": "Practitioner", "display": "Herman BH", "reference": "#contributor15"}, "forenameInitials": "BH"}], "complete": true}, "publicationForm": [{"issue": "1-2", "volume": "97", "pageString": "158-68", "articleDate": "2008-09-01", "citedMedium": {"coding": [{"code": "print", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Print"}]}, "publishedIn": {"type": {"coding": [{"code": "D020492", "system": "http://terminology.hl7.org/CodeSystem/published-in-type", "display": "Periodical"}]}, "title": "Drug and alcohol dependence", "identifier": [{"type": {"text": "Print ISSN Type", "coding": [{"code": "Print", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "display": "Print"}]}, "value": "0376-8716", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Drug Alcohol Depend", "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/"}, {"type": {"text": "ISSN Linking", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "0376-8716", "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/"}, {"type": {"text": "Medline Title Abbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Drug Alcohol Depend", "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html"}, {"type": {"text": "NLM Unique ID", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "7513587", "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local"}], "publisherLocation": "Ireland"}}, {"articleDate": "2008-05-27", "citedMedium": {"coding": [{"code": "internet-without-issue", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Internet without issue"}]}}]}, "classification": [{"type": {"coding": [{"code": "citation-source", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"code": "medline-owner", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"code": "NLM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "lastReviewDate": "2021-10-20", "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."}